Related Experiment Video
Updated: Jun 11, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Translation Initiation Factor-2S2 (eIF2S2) Contributes to Cervical Carcinogenesis by Inhibiting the TGF-β/SMAD4
Juthika Kundu1, Hobin Yang2, Saerom Moon3
1Lika shing applied virology institute, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
Abstract:
The deregulation of protein translational machinery and the oncogenic role of several translation initiation factors have been extensively investigated. This study aimed to investigate the role of eukaryotic translation initiation factor 2S2 (eIF2S2, also known as eIF2β) in cervical carcinogenesis. Immunohistochemical analysis of human cervical carcinoma tissues revealed a stage-specific increase in eIF2S2 expression. The knockdown of eIF2S2 in human cervical cancer (SiHa) cells significantly reduced growth and migration properties, whereas its overexpression demonstrated the opposite effect. Immunoprecipitation and Bimolecular fluorescence complementation (BiFC) assay confirmed the previous photo array finding of the interaction between eIF2S2 and SMAD4 to understand the tumorigenic mechanism of eIF2S2. The results indicated that the N-terminus of eIF2S2 interacts with the MH-1 domain of SMAD4. The interaction effect between eIF2S2 and SMAD4 was further evaluated. The knockdown of eIF2S2 increased SMAD4 expression in cervical cancer cells without changing SMAD4 mRNA expression, whereas transient eIF2S2 overexpression reduced SMAD4 expression. This indicates the possibility of post-translational regulation of SMAD4 expression by eIF2S2. Additionally, eIF2S2 overexpression was confirmed to weaken the expression and/or promoter activity of p15 and p27, which are SMAD4-regulated antiproliferative proteins, by reducing SMAD4 levels. Therefore, our study indicated the pro-tumorigenic role of eIF2S2, which diminishes both SMAD4 expression and function as a transcriptional factor in cervical carcinogenesis.
Insights
Eukaryotic translation initiation factor 2S2 (eIF2S2) promotes cervical cancer growth and migration. This factor interacts with SMAD4, reducing its expression and the activity of tumor-suppressing proteins p15 and p27.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Deregulation of protein translation is implicated in cancer.
- The role of translation initiation factors in cervical carcinogenesis is not fully understood.
Purpose of the Study:
- To investigate the role of eukaryotic translation initiation factor 2S2 (eIF2S2) in cervical cancer.
- To elucidate the molecular mechanisms underlying eIF2S2's function in cervical carcinogenesis.
Main Methods:
- Immunohistochemical analysis of cervical carcinoma tissues.
- Cell-based assays including knockdown and overexpression of eIF2S2 in SiHa cells.
- Immunoprecipitation and Bimolecular fluorescence complementation (BiFC) assays to study protein interactions.
Main Results:
- eIF2S2 expression increased with cervical cancer stage.
- eIF2S2 knockdown inhibited cancer cell growth and migration; overexpression enhanced these properties.
- eIF2S2 directly interacts with SMAD4, affecting its post-translational regulation.
- eIF2S2 overexpression reduced SMAD4 levels, subsequently decreasing the expression and promoter activity of antiproliferative proteins p15 and p27.
Conclusions:
- eIF2S2 plays a pro-tumorigenic role in cervical carcinogenesis.
- eIF2S2 diminishes SMAD4 expression and its function as a transcriptional factor, contributing to tumor development.
Related Concept Videos
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Inhibition of Cdk Activity
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Abnormal Proliferation

